Successful Treatment of Antihypertensive Overdose Using Intravenous Angiotensin II.

[1]  R. Bellomo,et al.  Angiotensin converting enzyme defects in shock: implications for future therapy , 2018, Critical Care.

[2]  L. Busse,et al.  Angiotensin II: a new therapeutic option for vasodilatory shock , 2018, Therapeutics and clinical risk management.

[3]  M. Ostermann,et al.  Angiotensin in Critical Care , 2018, Critical Care.

[4]  M. McCurdy,et al.  The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature , 2017, Critical Care.

[5]  D. Spyker,et al.  2016 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th Annual Report , 2017, Clinical toxicology.

[6]  A. Khanna,et al.  Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety , 2017, Critical care medicine.

[7]  R. Bellomo,et al.  Angiotensin II for the Treatment of Vasodilatory Shock , 2017, The New England journal of medicine.

[8]  P. Hantson,et al.  Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults , 2017, Critical care medicine.

[9]  Yuguo Chen,et al.  Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis , 2014, Experimental and therapeutic medicine.

[10]  R. Clark,et al.  Utilization of Hyperinsulinemia Euglycemia and Intravenous Fat Emulsion Following Poison Center Recommendations , 2013, Journal of Medical Toxicology.

[11]  S. Aks,et al.  Hyperinsulin Therapy for Calcium Channel Antagonist Poisoning: A Seven-Year Retrospective Study , 2013, American journal of therapeutics.

[12]  J. Poitras,et al.  Adherence to calcium channel blocker poisoning treatment recommendations in two Canadian cities , 2012, Clinical toxicology.

[13]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[14]  C. Yunis,et al.  Differential actions of angiotensin-(1-7) in the kidney. , 1998, Kidney international. Supplement.

[15]  J. Ruiz,et al.  Treatment of severe combined overdose of calcium antagonists and converting enzyme inhibitors with angiotensin II. , 1997, Nephron.

[16]  N. Martell,et al.  Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension , 1996, Journal of hypertension.

[17]  H. Margolius.  Kallikreins and Kinins: Molecular Characteristics and Cellular and Tissue Responses , 1996, Diabetes.

[18]  R. Ferner,et al.  Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. , 1995, Journal of human hypertension.

[19]  J. Ménard,et al.  Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. , 1995, Circulation.

[20]  D. Newby,et al.  Enalapril overdose and the corrective effect of intravenous angiotensin II. , 1995, British journal of clinical pharmacology.

[21]  K. A. Johnson,et al.  Lisinopril Overdose and Management with Intravenous Angiotensin II , 1994, The Annals of pharmacotherapy.

[22]  C. Corke,et al.  Enalapril overdose treated with angiotensin infusion , 1993, The Lancet.

[23]  E. Nelson,et al.  Consequences of angiotensin-converting enzyme inhibitor overdose. , 1989, American journal of hypertension.